Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Validation of α-Synuclein in L1CAM-Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian Syndromes.

Jiang C. et al, (2021), Mov Disord

Facile impedimetric analysis of neuronal exosome markers in Parkinson's disease diagnostics

FU Y. et al, (2020), Analytical Chemistry

Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism.

Jiang C. et al, (2020), J Neurol Neurosurg Psychiatry

How is alpha-synuclein cleared from the cell?

Stefanis L. et al, (2019), Journal of Neurochemistry

Monitoring α-Synuclein Proteotoxicity in Drosophila Models.

Szabo A. and Tofaris GK., (2019), Methods Mol Biol, 1948, 199 - 208

Convergent molecular defects underpin diverse neurodegenerative diseases.

Tofaris GK. and Buckley NJ., (2018), J Neurol Neurosurg Psychiatry, 89, 962 - 969

Stem cell modeling of mitochondrial parkinsonism reveals key functions of OPA1.

Jonikas M. et al, (2018), Ann Neurol, 83, 915 - 925

A Critical Assessment of Exosomes in the Pathogenesis and Stratification of Parkinson's Disease.

Tofaris G., (2017), npj Parkinson's Disease

The Transcellular Propagation and Intracellular Trafficking of α-Synuclein.

Tofaris GK. et al, (2017), Cold Spring Harb Perspect Med, 7

Identification of Usp8 as a toxicity modifying Deubiquitinase for alpha-synuclein

Alexopoulou Z. et al, (2017), EUROPEAN JOURNAL OF NEUROLOGY, 24, 766 - 766

Concentration-Normalized Electroanalytical Assaying of Exosomal Markers.

Li Q. et al, (2017), Anal Chem, 89, 3184 - 3190

A Critical Assessment of Exosomes in the Pathogenesis and Stratification of Parkinson's Disease

Tofaris GK., (2017), Journal of Parkinson's Disease, 7, 569 - 576

PUPILLARY REWARD SENSITIVITY IS A MARKER OF APATHY IN PARKINSON'S DISEASE

Muhammed K. et al, (2016), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 87

Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson's disease.

Muhammed K. et al, (2016), Brain, 139, 2706 - 2721

Deubiquitinase Usp8 regulates α-synuclein clearance and modifies its toxicity in Lewy body disease.

Alexopoulou Z. et al, (2016), Proc Natl Acad Sci U S A, 113, E4688 - E4697

ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons.

Fernandes HJR. et al, (2016), Stem Cell Reports, 6, 342 - 356

Intact Acquisition and Short-Term Retention of Non-Motor Procedural Learning in Parkinson's Disease.

Panouillères MTN. et al, (2016), PLoS One, 11

REWARD SENSITIVITY DEFICITS UNDERLIE APATHY IN PARKINSON'S DISEASE

Muhammed K. et al, (2015), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 86

Dopamine enhances willingness to exert effort for reward in Parkinson's disease.

Chong TT-J. et al, (2015), Cortex, 69, 40 - 46

Apathy in Parkinson's disease is associated with reward sensitivity deficits

Muhammed K. et al, (2015), EUROPEAN JOURNAL OF NEUROLOGY, 22, 67 - 67

Load More

Include forthcoming?